DSG3 and neoplasm: To confirm the proof of concept in non-clinical models, we attempted to generate an anti-mouse DSG3 mAb that has anti-tumour activity by ADCC to SCC, but with no cell–cell dissociating effects in keratinocytes that cause PV (Fig. 2A).